How Can You Avoid The Fallout From Incompatibility Between Your API And Its Formulation?
PATHEON SPONSORED CONTENT

How Can You Avoid The Fallout From Incompatibility Between Your API And Its Formulation?

In drug development, designing a formulation for a drug product calls for careful attention to both the physical and chemical properties of the active pharmaceutical ingredient (API or drug substance). Additionally, it is critical the experts creating the formulation are aware of any reactions that can occur between an API and a tablet’s excipients. This enables the correct choice of excipients, avoids unpleasant surprises at a later stage and allows the focus to remain upon the manufacturing scale-up of both the drug substance and the formulated product. This white paper explores ways a pharmaceutical company can recognize both unfavorable drug substance properties and incompatibility between an API and its formulation, and solutions to avoid potential risks to the patient as well as costly interruptions during development. Download now to learn more.

Download the Document

    * denotes a required field

    Please fill out the information below. If you are already registered, and this information will be filled out for you.

  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the e-mail address you would like to be contacted at.

  • Please enter the phone number you would like to be contacted at.

    • By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.